课题基金 / 基金详情

Defining the intestinal stem cell niche during organoid development into a functional human intestine

Defining the intestinal stem cell niche during organoid development into a functional human intestine
定义类器官发育成功能性人类肠道过程中的肠道干细胞生态位
批准号:
10229471
负责人:
MICHAEL A. HELMRATH
金额:
$39.73万
依托单位国家:
美国
项目类别:
财政年份:
2014
资助国家:
美国
项目状态:
已结题
起止时间:
2014-09-01 至 2024-08-31

项目摘要

项目成果

MICHAEL A. HELMRATH的其他基金

相似基金

相关文献

中文摘要
翻译
摘要 这一建议利用了我们最近开发的体外培养人类多能干细胞的方法。 衍生的肠道和结肠器官(HIO/HCO),与我们独特的器官移植相结合 识别支持小细胞和大细胞的特定间充质和内胚层壁龛细胞类型的模型 肠子。在肠道干细胞联盟(ISCC)内完成的这项工作的临床意义在于它 将帮助我们的团队确定最佳的ISC利基组件,从而支持 功能性人类区域化肠道移植及再生损伤所需的治疗 肠子。我们的初步数据表明,记者工具和重组的成功开发 用尖端分子方法定位特定间充质和内胚层种群的方法 确定支持人类ISC的特定信号通路和活体人类肠道模型进行研究 全身化疗后的再生。
英文摘要
Abstract This proposal capitalizes on our recently developed in vitro methods to culture human pluripotent stem cell derived intestinal and colonic organoids (HIO/HCO), combined with our unique organoid transplantation models to identify specific mesenchymal and endodermal niche cell types that support the small and large intestine. The clinical relevance of this work done within the Intestinal Stem Cell Consortium (ISCC) is that it will contribute to our groups effort to identify optimal ISC niche components that will enable both transplantation of functional human regionalized intestine and inform therapies required to regenerate damage intestine. Our preliminary data demonstrates the successful development of reporter tools and recombination assays to localize specific mesenchymal and endodermal populations with cutting edge molecular approaches to identify specific signal pathways supporting the human ISC and in vivo human intestinal models to study regeneration following systemic administration of chemotherapy.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Surgical or Medical Treatment for Pediatric Type 2 Diabetes (ST2OMP)
  • 批准号:
    10247673
  • 项目类别:
  • 资助金额:
    $66.15万
  • 财政年份:
    2019
  • 负责人:
    MICHAEL A. HELMRATH
  • 依托单位:
Surgical or Medical Treatment for Pediatric Type 2 Diabetes (ST2OMP)
  • 批准号:
    10477072
  • 项目类别:
  • 资助金额:
    $65.57万
  • 财政年份:
    2019
  • 负责人:
    MICHAEL A. HELMRATH
  • 依托单位:
Surgical or Medical Treatment for Pediatric Type 2 Diabetes (ST2OMP)
  • 批准号:
    10016312
  • 项目类别:
  • 资助金额:
    $66.97万
  • 财政年份:
    2019
  • 负责人:
    MICHAEL A. HELMRATH
  • 依托单位:
Surgical or Medical Treatment for Pediatric Type 2 Diabetes (ST2OMP)
  • 批准号:
    9816186
  • 项目类别:
  • 资助金额:
    $69.04万
  • 财政年份:
    2019
  • 负责人:
    MICHAEL A. HELMRATH
  • 依托单位:
海外基金